Literature DB >> 16301636

Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.

Jens Schümann1, Paola Pittoni, Elena Tonti, H Robson Macdonald, Paolo Dellabona, Giulia Casorati.   

Abstract

CD1d-dependent invariant Valpha14 (Valpha14i) NKT cells are innate T lymphocytes expressing a conserved semi-invariant TCR, consisting, in mice, of the invariant Valpha14-Jalpha18 TCR alpha-chain paired mostly with Vbeta8.2 and Vbeta7. The cellular requirements for thymic positive and negative selection of Valpha14i NKT cells are only partially understood. Therefore, we generated transgenic mice expressing human CD1d (hCD1d) either on thymocytes, mainly CD4+ CD8+ double positive, or on APCs, the cells implicated in the selection of Valpha14i NKT cells. In the absence of the endogenous mouse CD1d (mCD1d), the expression of hCD1d on thymocytes, but not on APCs, was sufficient to select Valpha14i NKT cells that proved functional when activated ex vivo with the Ag alpha-galactosyl ceramide. Valpha14i NKT cells selected by hCD1d on thymocytes, however, attained lower numbers than in control mice and expressed essentially Vbeta8.2. The low number of Vbeta8.2+ Valpha14i NKT cells selected by hCD1d on thymocytes was not reversed by the concomitant expression of mCD1d, which, instead, restored the development of Vbeta7+ Valpha14i NKT cells. Vbeta8.2+, but not Vbeta7+, NKT cell development was impaired in mice expressing both hCD1d on APCs and mCD1d. Taken together, our data reveal that selective CD1d expression by thymocytes is sufficient for positive selection of functional Valpha14i NKT cells and that both thymocytes and APCs may independently mediate negative selection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301636     DOI: 10.4049/jimmunol.175.11.7303

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

Review 2.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

Review 3.  Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Luc Van Kaer; Lan Wu; Vrajesh V Parekh
Journal:  Immunology       Date:  2015-06-22       Impact factor: 7.397

Review 4.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

5.  Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.

Authors:  Fenna C M Sillé; Constance Martin; Pushpa Jayaraman; Alissa Rothchild; Gurdyal S Besra; Samuel M Behar; Marianne Boes
Journal:  Immunol Lett       Date:  2011-05-05       Impact factor: 3.685

Review 6.  ID'ing innate and innate-like lymphoid cells.

Authors:  Mihalis Verykokakis; Erin C Zook; Barbara L Kee
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

7.  Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.

Authors:  Michael I Zimmer; Hanh P Nguyen; Bin Wang; Honglin Xu; Angela Colmone; Kyrie Felio; Hak-Jong Choi; Ping Zhou; Maria-Luisa Alegre; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

8.  Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.

Authors:  Xiangshu Wen; Ping Rao; Leandro J Carreño; Seil Kim; Agnieszka Lawrenczyk; Steven A Porcelli; Peter Cresswell; Weiming Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  MHC class II-expressing thymocytes suppress invariant NKT cell development.

Authors:  Wei Li; M Hanief Sofi; Datsen G Wei; Wenjun Du; Jacquelyn Gervay-Hague; Gourapura J Renukaradhya; Randy R Brutkiewicz; Cheong-Hee Chang
Journal:  Immunol Cell Biol       Date:  2008-11-04       Impact factor: 5.126

10.  Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway.

Authors:  Joy A Williams; Joanne M Lumsden; Xiang Yu; Lionel Feigenbaum; Jingjing Zhang; Seth M Steinberg; Richard J Hodes
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.